Clinical trial
HPV Methylation Self-testing Pilot in Transgender Individuals
NCT05883111 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HPV Methylation Self-testing Pilot in Transgender Individuals
- Lead sponsor
- Queen Mary University of London
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 29, 2024
- Completion date
- November 29, 2026
- Enrollment
- 100 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hpv infection